Versafitcup® DM was introduced into the market in 2003 and we are pleased to announce 10 years of clinical success of this double mobility cup.
Since 2003, over 15,000 Versafitcup® DM implants have been used, proving it to be a reliable solution for hip arthroplasty, especially in cases where hip stability may have been a problem. Versafitcup® DM specifically addresses hip stability as it was designed to have the highest jumping distance in the market in order to decrease the risk of hip dislocation1. A recent study by Laffargue et al reported 0% of dislocation rate after 5 years and 99.2% survival rate using revision for any reason as the endpoint and 100% excluding septic failures2.
The Versafitcup® DM, together with the low dislocation rate, also provides an increased range of motion and a drastic reduction of PE wear, thus increasing its survival rate.
The Versafitcup® DMs excellent performance and success could not be possible without the surgeons who work with Medacta®. We take this opportunity to thank them all!
1Spadini E, Quagliana I, Siccardi F, Bernardoni M, Ponzoni M. Impact of cup design in reducing the risk of dislocation. M.O.R.E. Journal, 2 17-21, January 2012
2Laffargue P, Roumazeille T, Soenen M, Migaud H. Versafitcup® double mobility cup: outcomes at a mean follow-up of 5 years. Poster presentation at the 12th EFORT Congress, Copenhagen, Denmark, 1-4 June 2011
